RAPP
Rapport Therapeutics Inc.
$30.27
+$1.49(+5.18%)
56
Overall
60
Value
66
Tech
44
Quality
Market Cap
$1.37B
Volume
312.88K
52W Range
$6.43 - $42.27
Target Price
$51.50
Key Metrics Overview
| Market Cap | $1.37B | P/E Ratio | N/A |
| 52W High | $42.27 | 52W Low | $6.43 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | N/A | 52W Position | 66.5% |
| Overall Score | 56 | Value Score | 60 |
| Quality Score | 44 | Technical Score | 66 |
Growth Analysis
| EPS Current Est | $-2.79 | EPS Next Est | $-3.41 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
No data available
EBITDA (5Y)
No data available
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RAPP | $30.27 | +5.2% | 312.88K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Rapport Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW